ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1915

Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting

Martha Delgado1, Cassidy Hernandez-Tamayo2, Melissa Wilson2 and Leanna Wise3, 1Los Angeles General Hospital/Keck Medicine of USC, Costa Mesa, CA, 2Keck School of Medicine of USC, Los Angeles, CA, 3LAGMC/Keck Medicine of USC, Los Angeles, CA

Meeting: ACR Convergence 2024

Keywords: Juvenile Inflammatory Arthritis, race/ethnicity, rheumatoid arthritis, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Healthcare Disparities in Rheumatology Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Timely reproductive health conversations in the rheumatology outpatient setting are essential for optimal maternal-fetal health; however, the literature suggests that these conversations happen for only 50% of encounters with rheumatic disease patients of childbearing age. In this study, we gathered patient-reported insight into the difficulties encountered when discussing reproductive health issues in the outpatient setting in a primarily Hispanic population in urban Los Angeles.

Methods: A cross-sectional survey derived from the 2020 ACR Reproductive Health Guideline was distributed in English or Spanish to female patients ages 18-50 with systemic lupus erythematosus (SLE) or rheumatoid arthritis/juvenile idiopathic arthritis (inflammatory arthritis; IA) seen in our academic outpatient rheumatology clinic in the Los Angeles metropolitan area in late 2023. Participants were queried as to reasons they perceive difficulty in discussing contraception and pregnancy with their lupus/arthritis doctor; responses were analyzed based on participants’ diagnosis (SLE vs IA) and language preference (English vs Spanish). Questions regarding OB-GYN referral and language barriers were combined in all surveys and analyzed as a unit due to an unintentional error. Univariate logistic regression was used to assess the relationship between diagnosis, preferred language, and barriers to reproductive health discussions. A two-sided p-value of < 0.05 was considered statistically significant.

Results: 153 SLE and 151 IA participants were analyzed (Table 1). Most participants identified as Hispanic (91.4%) and had a Spanish survey preference (62.5%) (Table 1). Spanish respondents were more likely to note a deferral to OB-GYN or have a language barrier (OR 1.95; 95% CI 1.08-3.55; p=0.03), less likely to consider issues of reproductive health not relevant to them (OR 0.30; 95% CI 0.13-0.71; p=0.01) and less likely to report no barriers to reproductive health discussions (OR 0.61; 95% CI 0.38-0.99; p=0.05) vs. English respondents (Table 2). IA participants were more likely to be referred to an OB-GYN or have a language barrier (OR 1.80; 95% 1.04-3.11; p=0.04) and were borderline less likely to feel that pregnancy was unsafe for them (OR 0.59; 95% CI 0.32-1.07; p=0.08) compared with SLE patients (Table 2). There were no differences in appointment time, perceived clinician knowledge, or patient comfort level. Of note, 37.7% of SLE participants and 33.1% of IA participants noted no barriers to discussing reproductive health.

Conclusion: Our study sheds light on the patient’s perspective, and highlights language or OB-GYN referrals as limitations to engaging in reproductive health discussions with the rheumatologist. Further studies isolating language as a possible barrier are needed for non-English speaking populations. The large proportion of participants (over a third of the total) who had no barriers in discussing reproductive-related issues suggests that interventions targeting clinicians may also be helpful.

Supporting image 1

Supporting image 2


Disclosures: M. Delgado: None; C. Hernandez-Tamayo: None; M. Wilson: None; L. Wise: AstraZeneca, 1, 6, Aurinia Pharma, 5, 6, GlaxoSmithKlein(GSK), 6.

To cite this abstract in AMA style:

Delgado M, Hernandez-Tamayo C, Wilson M, Wise L. Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/patient-reported-difficulties-regarding-reproductive-health-discussions-in-an-urban-outpatient-setting/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-difficulties-regarding-reproductive-health-discussions-in-an-urban-outpatient-setting/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology